Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
STAR-1 topline results expected in March 2025 - - Over 30 million acne patients seek treatment in the U.S. each year - - Phase 2b for DMT310 achieved statistically significant r ...
Medscape1 天
Expert Discusses the ‘Four Pillars of Acne Pathogenesis’
The average number of acne products used per patient is 2.53, but that’s also the average number of copays,” Shanna Miranti ...
rheumatologyadvisor8 天
Majority of New Opioid Prescriptions in the UK Indicated for Musculoskeletal Conditions
New opioid prescriptions for patients in the UK mostly written for musculoskeletal conditions, in which there is little evidence for opioid efficacy.
The Lancet22 天
Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist
eDivision of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA fDivision of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA ...